Protedyne to Use $12M VC Infusion to Bolster Staff, Ramp Development | GenomeWeb

NEW YORK, Nov. 1 – A recent $12 million private equity infusion has spurred Protedyne to expand its manufacturing operations and hire on 30 new staff, the company said on Thursday.

Protedyne, based in Windsor, Conn., said that the capital also will be used to help the research-automation firm bolster its new BioCube and BioResearch products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."